Jian Min Fang
Chief Executive Officer presso REMEGEN CO., LTD.
Patrimonio netto: 84 M $ in data 31/03/2024
Profilo
Jian Min Fang ha fondato RemeGen Co., Ltd. e MabPlex International Ltd. Il Dr. Fang ricopre la posizione di presidente di MabPlex International Ltd. e di CEO, direttore esecutivo e responsabile scientifico di RemeGen Co. Il Dr. Fang è anche nel consiglio di amministrazione della Chinese Pharmaceutical Association, Remegen Medical Research Shanghai Co. Ltd., Remegen Biosciences, Inc. e Remegen Hong Kong Ltd. e Vice Presidente-Antibody Drug Division presso la China Medicinal Biotech Association. Il Dr. Fang ha ricevuto un dottorato dalla Dalhousie University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
REMEGEN CO. LTD. CLASS H
12.79% | 01/10/2023 | 24 244 500 ( 12.79% ) | 84 M $ | 31/03/2024 |
Posizioni attive di Jian Min Fang
| Società | Posizione | Inizio |
|---|---|---|
| REMEGEN CO., LTD. | Chief Executive Officer | 04/07/2008 |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Founder | 25/06/2013 |
| Remegen Medical Research Shanghai Co. Ltd. | Director/Board Member | - |
| Remegen Biosciences, Inc. | Director/Board Member | - |
| Remegen Hong Kong Ltd. | Director/Board Member | - |
| Chinese Pharmaceutical Association | Director/Board Member | - |
| China Medicinal Biotech Association | Corporate Officer/Principal | - |
Formazione di Jian Min Fang
| Dalhousie University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REMEGEN CO., LTD. | Health Technology |
| Aziende private | 6 |
|---|---|
| Chinese Pharmaceutical Association | |
| China Medicinal Biotech Association | |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
| Remegen Medical Research Shanghai Co. Ltd. | |
| Remegen Biosciences, Inc. | |
| Remegen Hong Kong Ltd. |
- Borsa valori
- Insiders
- Jian Min Fang
